abstract |
The present invention relates to a compound of formula I, [Chemical 1] Compositions comprising such compounds, use of such compounds in therapy (eg, in the treatment or prevention of diseases, disorders, or conditions that ameliorate by inhibition of dopamine transporters) and methods of treating patients with such compounds Wherein R 1 , R 2 , R 3 , R 4 , R 9a , R 9b , R 9c , R 9d , R 9e , R 9f , m, n, A, L, and B are as defined herein. As defined in the book. [Selection figure] None |